{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:14:19Z","timestamp":1649157259718},"reference-count":27,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2019.11174","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T11:59:31Z","timestamp":1575287971000},"source":"Crossref","is-referenced-by-count":0,"title":["A gene\u2011expression\u2011based test can outperform bap1 and p16 analyses in the differential diagnosis of pleural mesothelial proliferations"],"prefix":"10.3892","author":[{"given":"Greta","family":"Al\ufffd","sequence":"first","affiliation":[{"name":"Unit of Pathological Anatomy, Azienda Ospedaliero Universitaria Pisana, AOUP, Pisa, I\u201156126 Tuscany, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Bruno","sequence":"additional","affiliation":[{"name":"Unit of Pathological Anatomy, Azienda Ospedaliero Universitaria Pisana, AOUP, Pisa, I\u201156126 Tuscany, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anello","family":"Poma","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, I\u201156126 Tuscany, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnese","family":"Proietti","sequence":"additional","affiliation":[{"name":"Unit of Pathological Anatomy, Azienda Ospedaliero Universitaria Pisana, AOUP, Pisa, I\u201156126 Tuscany, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Ricci","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, I\u201156126 Tuscany, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Chella","sequence":"additional","affiliation":[{"name":"Unit of Pneumology, Azienda Ospedaliero Universitaria Pisana, AOUP, Pisa, I\u201156126 Tuscany, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franca","family":"Melfi","sequence":"additional","affiliation":[{"name":"Unit of Minimally Invasive and Robotic Thoracic Surgery, Robotic Multispeciality Center for Surgery, Azienda Ospedaliero Universitaria Pisana, AOUP, Pisa, I\u201156126 Tuscany, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Ambrogi","sequence":"additional","affiliation":[{"name":"Unit of Thoracic Surgery, Azienda Ospedaliero Universitaria Pisana, AOUP, Pisa, I\u201156126 Tuscany, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Lucchi","sequence":"additional","affiliation":[{"name":"Unit of Thoracic Surgery, Azienda Ospedaliero Universitaria Pisana, AOUP, Pisa, I\u201156126 Tuscany, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Fontanini","sequence":"additional","affiliation":[{"name":"Program of Pleuropulmonary Pathology, Azienda Ospedaliero Universitaria Pisana, AOUP, Pisa, I\u201156126 Tuscany, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"key":"key20200714151756_b1-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the European respiratory society and the European society of thoracic surgeons for the management of malignant pleural mesothelioma","volume":"35","author":"Scherpereel","year":"2010","journal-title":"Eur Respir J"},{"key":"key20200714151756_b2-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","article-title":"Molecular pathogenesis of malignant mesothelioma","volume":"34","author":"Sekido","year":"2013","journal-title":"Carcinogenesis"},{"key":"key20200714151756_b3-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"key20200714151756_b4-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.21037\/jtd.2017.10.125","article-title":"The pathological and molecular diagnosis of malignant pleural mesothelioma: A literature review","volume":"10","author":"Al\u00ec","year":"2018","journal-title":"J Thorac Dis"},{"key":"key20200714151756_b5-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J Thorac Oncol"},{"key":"key20200714151756_b6-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/1742-6413.170726","article-title":"Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology","volume":"12","author":"Hjerpe","year":"2015","journal-title":"Cytojournal"},{"key":"key20200714151756_b7-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"S342","DOI":"10.21037\/jtd.2017.10.88","article-title":"Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: A literature review","volume":"10","author":"Bruno","year":"2018","journal-title":"J Thorac Dis"},{"key":"key20200714151756_b8-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"318","DOI":"10.5858\/arpa.2015-0240-SA","article-title":"New markers for separating benign from malignant mesothelial proliferations: Are we there yet?","volume":"140","author":"Churg","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"key20200714151756_b9-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/j.lungcan.2005.03.017","article-title":"Implications of P16\/CDKN2A deletion in pleural mesotheliomas","volume":"49","author":"Ladanyi","year":"2005","journal-title":"Lung Cancer"},{"key":"key20200714151756_b10-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/cncr.10923","article-title":"The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions","volume":"99","author":"Illei","year":"2003","journal-title":"Cancer"},{"key":"key20200714151756_b11-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00428-008-0689-3","article-title":"Prognostic significance of p16\/cdkn2a loss in pleural malignant mesotheliomas","volume":"453","author":"Dacic","year":"2008","journal-title":"Virchows Arch"},{"key":"key20200714151756_b12-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1136\/jcp.2010.076794","article-title":"FISH assay development for the detection of p16\/CDKN2A deletion in malignant pleural mesothelioma","volume":"63","author":"Chung","year":"2010","journal-title":"J Clin Pathol"},{"key":"key20200714151756_b13-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/PAS.0000000000000394","article-title":"BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations","volume":"39","author":"Sheffield","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"key20200714151756_b14-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.18632\/oncotarget.13174","article-title":"Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis","volume":"8","author":"Bruno","year":"2017","journal-title":"Oncotarget"},{"key":"key20200714151756_b15-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","article-title":"Introduction to the 2015 World Health Organization Classification of tumors of the lung, pleura, thymus, and heart","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"key20200714151756_b16-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod Pathol"},{"key":"key20200714151756_b17-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.humpath.2015.06.024","article-title":"BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma","volume":"46","author":"McGregor","year":"2015","journal-title":"Hum Pathol"},{"key":"key20200714151756_b18-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.humpath.2016.09.026","article-title":"BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma","volume":"60","author":"McGregor","year":"2017","journal-title":"Hum Pathol"},{"key":"key20200714151756_b19-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/modpathol.2008.45","article-title":"Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas","volume":"21","author":"Chiosea","year":"2008","journal-title":"Mod Pathol"},{"key":"key20200714151756_b20-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1309\/AJCPP5R2ZJZKCLWN","article-title":"The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations","volume":"135","author":"Monaco","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"key20200714151756_b21-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1097\/00000478-200009000-00001","article-title":"The separation of benign and malignant mesothelial proliferations","volume":"24","author":"Churg","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"key20200714151756_b22-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1309\/AJCPOI1DESU8MTHZ","article-title":"Mesothelial proliferations: Useful marker is not the same as a diagnostic one","volume":"141","author":"Husain","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"key20200714151756_b23-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","article-title":"High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma","volume":"10","author":"Nasu","year":"2015","journal-title":"J Thorac Oncol"},{"key":"key20200714151756_b24-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/PAS.0000000000000616","article-title":"Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"key20200714151756_b25-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/14737159.2017.1268533","article-title":"NanoString, a novel digital color-coded barcode technology: Current and future applications in molecular diagnostics","volume":"17","author":"Tsang","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"key20200714151756_b26-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/bjc.2013.731","article-title":"An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma","volume":"110","author":"Linton","year":"2014","journal-title":"Br J Cancer"},{"key":"key20200714151756_b27-ol-0-0-11174","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.3892\/ijo.2016.3566","article-title":"SORORIN and PLK1 as potential therapeutic targets in malignant pleural mesothelioma","volume":"49","author":"Kato","year":"2016","journal-title":"Int J Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T14:23:03Z","timestamp":1594736583000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2019.11174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,2]]},"references-count":27,"URL":"https:\/\/doi.org\/10.3892\/ol.2019.11174","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,2]]}}}